🇺🇸 FDA
Patent

US 12049520

Bicyclic peptide ligands specific for CD137

granted A61KA61K38/00A61K47/64

Quick answer

US patent 12049520 (Bicyclic peptide ligands specific for CD137) held by BicycleTx Limited expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61K47/64